(AKTX) Akari Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Akari Therapeutics | (AKTX) share price targets
Complete technical analysis of Akari Therapeutics (AKTX) by charts plus indicators, forecast predictions and share price targets for Akari Therapeutics (AKTX)
Akari Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-12-23 View latest technical analysis
10 day averaged volume of Akari Therapeutics is 60841
| Date | Daily Closing Price | Open | High | Low | Volume |
| 23 Mon Dec 2024 | 0.95 | 0.94 | 1.03 | 0.94 | 1.097 times |
| 20 Fri Dec 2024 | 0.97 | 0.97 | 1.01 | 0.95 | 0.604 times |
| 19 Thu Dec 2024 | 1.00 | 0.96 | 1.03 | 0.96 | 0.702 times |
| 18 Wed Dec 2024 | 0.96 | 1.00 | 1.02 | 0.96 | 1.338 times |
| 17 Tue Dec 2024 | 0.10 | 1.13 | 1.13 | 0.10 | 0.455 times |
| 16 Mon Dec 2024 | 0.99 | 1.01 | 1.01 | 0.95 | 1.095 times |
| 13 Fri Dec 2024 | 0.97 | 0.95 | 1.03 | 0.95 | 1.741 times |
| 12 Thu Dec 2024 | 0.96 | 0.98 | 1.16 | 0.96 | 1.049 times |
| 11 Wed Dec 2024 | 0.98 | 0.98 | 1.02 | 0.98 | 0.565 times |
| 10 Tue Dec 2024 | 1.00 | 1.12 | 1.17 | 0.93 | 1.583 times |
My analysis of stock is bearish for shortterm, and stock might move down till 0.7 or till 0.2. Use a stoploss of 1.17 and if the stock hits stoploss, then it can shoot up till 1.61
Share price targets for Akari Therapeutics (AKTX)
| Target Type | Value |
| Downside Target | 0.10 |
| Downside Target | 0.90 |
| Downside Target | 0.93 |
| Upside Target | 1.03 |
| Upside Target | 1.13 |
| Upside Target | 1.19 |
| Upside Target | 1.25 |
| Upside Target | 1.31 |
| Upside Target | 2.10 |
| Upside Target | 2.57 |
| Upside Target | 3.06 |
| Upside Target | 3.15 |
| Upside Target | 3.70 |
| Upside Target | 3.87 |
| Upside Target | 4.22 |
Intraday share price targets for Akari Therapeutics (AKTX)
| Target Type | Value |
| Downside Intraday Target | 0.92 |
| Downside Intraday Target | 0.88 |
| Upside Intraday Target | 1.01 |
| Upside Intraday Target | 1.06 |
| Upside Intraday Target | 0.97 |
Weekly technical analysis of Akari Therapeutics (AKTX)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 23 Mon Dec 2024 | 0.95 | 0.94 | 1.03 | 0.94 | 0.262 times |
| 20 Fri Dec 2024 | 0.97 | 1.01 | 1.13 | 0.10 | 0.722 times |
| 13 Fri Dec 2024 | 0.97 | 1.23 | 1.25 | 0.93 | 2.242 times |
| 26 Tue Nov 2024 | 1.14 | 1.10 | 1.19 | 0.90 | 0.449 times |
| 26 Tue Nov 2024 | 1.14 | 1.30 | 1.31 | 0.90 | 0.465 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Akari Therapeutics (AKTX)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 23 Mon Dec 2024 | 0.95 | 1.23 | 1.25 | 0.10 | 0.456 times |
| 26 Tue Nov 2024 | 1.14 | 2.54 | 3.15 | 0.90 | 5.624 times |
| 31 Thu Oct 2024 | 2.40 | 2.78 | 3.70 | 2.10 | 0.73 times |
| 30 Mon Sep 2024 | 2.95 | 3.75 | 3.87 | 2.57 | 0.987 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Akari Therapeutics (AKTX)
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Akari Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Akari Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Akari Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Akari Therapeutics in short term but SELL signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Akari Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.94 and Akari Therapeutics (AKTX) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Akari Therapeutics (AKTX) stock. Volume based technical analysis of Akari Therapeutics (AKTX) stock is negative.
Akari Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Akari Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Akari Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Akari Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Akari Therapeutics in short term but SELL signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Akari Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.94 and Akari Therapeutics (AKTX) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Akari Therapeutics (AKTX) stock. Volume based technical analysis of Akari Therapeutics (AKTX) stock is negative.
Akari Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.